Report overview
Iron is considered as an essential element which plays an important role in many vital biological processes such as the formation of myoglobin, neurotransmitter production, energy metabolism, the formation of collagen and immune system function, and others.Intravenous Iron Therapy is usually preferred over oral iron therapy. This is majorly due to the advantages of intravenous iron therapy, such as faster and higher increase in hemoglobin (Hb) levels and replenishment of body iron stores.
This report aims to provide a comprehensive presentation of the global market for Intravenous Iron Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous Iron Therapy. This report contains market size and forecasts of Intravenous Iron Therapy in global, including the following market information:
Global Intravenous Iron Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Intravenous Iron Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Iron Sucrose Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Intravenous Iron Therapy include American Regent, Inc., AMAG Pharmaceuticals, Inc, Fresenius Medical Care, Actavis Pharma, Inc. and Sanofi S.A., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Intravenous Iron Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Intravenous Iron Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Intravenous Iron Therapy Market Segment Percentages, by Type, 2022 (%)
Iron Sucrose
Ferric Gluconate
Ferric Carboxymaltose
Ferumoxytol
Others
Global Intravenous Iron Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Intravenous Iron Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
Global Intravenous Iron Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Intravenous Iron Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Intravenous Iron Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Intravenous Iron Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
American Regent, Inc.
AMAG Pharmaceuticals, Inc
Fresenius Medical Care
Actavis Pharma, Inc.
Sanofi S.A.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Intravenous Iron Therapy, market overview.
Chapter 2: Global Intravenous Iron Therapy market size in revenue.
Chapter 3: Detailed analysis of Intravenous Iron Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Intravenous Iron Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
